ÂÜÀòÂÒÂ×

Kemi Bankole has a varied and extensive work experience in the medical field. Kemi most recently worked at Sage Therapeutics as an Executive Medical Director since April 2022. Prior to this role, they served as a Senior Medical Director from April 2019 to March 2022 and as a Medical Director from November 2017 to April 2019 at the same company.

Prior to their time at Sage Therapeutics, Kemi worked at Takeda Pharmaceuticals Europe Ltd as a Medical Director from November 2014 to October 2017. Before that, they gained experience at MHRA as a Senior Medical Assessor from January 2014 to August 2014 and as a Medical Assessor from September 2008 to December 2013.

Kemi's earlier experiences include working as an Associate Director at Shire Pharmaceuticals from an unspecified date in 2004 to 2008. Kemi also worked as a Clinical Research Fellow at King's College Hospital NHS Trust (LIRN) from June 2003 to May 2004, as a Specialist Registrar at Homerton University Hospital NHS Foundation Trust from February 2003 to April 2003, as a Senior House Officer at Royal Free NHS trust from August 2002 to February 2003, and as a Senior House Officer at Mayday University Hospital from August 2000 to August 2002.

Overall, Kemi Bankole has a diverse background in medical leadership and assessment roles, with a range of experiences in pharmaceuticals, regulatory agencies, and healthcare facilities.

Kemi Bankole completed their primary education at Croham Hurst School from 1988 to 1992. Following this, they attended Cambridge Tutors College from 1992 to 1994. Finally, they pursued higher education at Cardiff University / Prifysgol Caerdydd from 1994 to 1999, where they earned a degree in Medicine (MBBCh).